The global biomarkers market is undergoing a transformative expansion, fueled by rapid advancements in precision medicine, drug discovery, and omics technologies. Valued at USD 62.39 billion in 2025, the market is projected to reach an impressive USD 104.15 billion by 2030, growing at a CAGR of 10.8%